Actively Recruiting
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
Led by Chinese PLA General Hospital · Updated on 2020-04-28
1134
Participants Needed
1
Research Sites
361 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study was a prospective multicenter cohort control study, which was divided into 1:1 groups to compare the clinical efficacy of percutaneous microwave ablation and laparoscopic hepatocellular carcinoma resection (tumor diameter 3.1-5.0cm).
CONDITIONS
Official Title
To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Older than 18 years old, regardless of gender
- For patients without cirrhosis, hepatocellular carcinoma must be pathologically confirmed within 1 month before surgery
- For patients with cirrhosis, liver cancer diagnosis must be confirmed by specific MRI or CT scans showing characteristic vascular signs
- Number of tumors must be 3 or fewer, with at least one tumor sized 3.1 to 5.0 cm
- No evidence of blood vessel invasion, lymph node invasion, or distant metastasis
- Liver function classified as Child-Pugh A or B, assessed within 14 days before surgery
- Participants must understand the study purpose, participate voluntarily, and sign informed consent
You will not qualify if you...
- Severe liver failure, hepatic encephalopathy, large ascites, or gastrointestinal bleeding within 1 month
- Blood clotting problems or bleeding tendencies (platelet count less than 50 x 10^9/L or INR greater than 1.5)
- Severe heart, lung, or kidney insufficiency
- Active infections
- Pregnancy
- History of drug abuse or mental illness
- Inability to tolerate pneumoperitoneum (lung collapse during laparoscopy)
- Use of other anti-cancer treatments or participation in other studies within 4 weeks
- Any other factors deemed unsuitable by researchers affecting participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Chinese PLA General Hospital
Beijing, Beijing Municipality, China, 100853
Actively Recruiting
Research Team
J
Jie Yu, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here